Next Article in Journal
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
Next Article in Special Issue
Efficacy and Low Toxicity of Normo-Fractionated Re-Irradiation with Combined Chemotherapy for Recurrent Glioblastoma—An Analysis of Treatment Response and Failure
Previous Article in Journal
mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy
Previous Article in Special Issue
Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma
 
 
Article

Article Versions Notes

Cancers 2023, 15(17), 4422; https://doi.org/10.3390/cancers15174422
Action Date Notes Link
article xml file uploaded 4 September 2023 16:13 CEST Original file -
article xml uploaded. 4 September 2023 16:14 CEST Update -
article pdf uploaded. 4 September 2023 16:14 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4422/pdf-vor
article supplementary file uploaded. 4 September 2023 16:14 CEST - https://www.mdpi.com/2072-6694/15/17/4422#supplementary
article html file updated 4 September 2023 16:15 CEST Original file -
article xml file uploaded 5 September 2023 03:13 CEST Update -
article xml uploaded. 5 September 2023 03:13 CEST Update https://www.mdpi.com/2072-6694/15/17/4422/xml
article pdf uploaded. 5 September 2023 03:13 CEST Updated version of record https://www.mdpi.com/2072-6694/15/17/4422/pdf
article html file updated 5 September 2023 03:15 CEST Update -
article html file updated 5 September 2023 12:54 CEST Update https://www.mdpi.com/2072-6694/15/17/4422/html
Back to TopTop